Education to Reduce Opioid Use After Prostate Surgery
Evaluation of Pre-operative Education Modalities to Decrease Opioid Use in Prostate Cancer Patients: A Prospective Randomized Control Trial
NA · Benaroya Research Institute · NCT04933084
This study tests if giving patients education before prostate surgery can help them use fewer opioids afterward and improve their recovery.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Benaroya Research Institute (other) |
| Locations | 1 site (Seattle, Washington) |
| Trial ID | NCT04933084 on ClinicalTrials.gov |
What this trial studies
This trial investigates the impact of preoperative education on opioid use following robotic-assisted radical prostatectomy for prostate cancer. Participants will be randomized into three groups: usual care, a text handout, or a text handout combined with a pre-recorded video. The study aims to evaluate how these educational interventions affect postoperative opioid consumption, pain levels, and recovery outcomes. The trial will be conducted at Virginia Mason Medical Center and will measure both primary and secondary outcomes related to opioid use and patient satisfaction.
Who should consider this trial
Good fit: Ideal candidates are men aged 18 or older who are scheduled for robotic-assisted radical prostatectomy at Virginia Mason Medical Center.
Not a fit: Patients with a history of long-term opioid use or substance dependence may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce opioid consumption and improve recovery experiences for patients undergoing prostate surgery.
How similar studies have performed: Other studies have shown that educational interventions can effectively reduce opioid use, suggesting this approach may be promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18 * Undergoing RARP at VMMC * Consent to participate in the study Exclusion Criteria: * Long-term opioid use defined as use of opioids on most days for \>3 months * History of drug or alcohol dependence * Concurrent surgery during radical prostatectomy * History of allergy to opioid analgesics, NSAIDs, acetaminophen or local anesthetics * Inability or unwillingness to give written informed consent
Where this trial is running
Seattle, Washington
- Virginia Mason Medical Center — Seattle, Washington, United States (RECRUITING)
Study contacts
- Principal investigator: Una Lee, MD — Virginia Mason Medical Center
- Study coordinator: Eyal Kord, MD
- Email: Eyal.Kord@virginiamason.org
- Phone: 206-223-6772
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Prostatectomy, Opioid-Related Disorders, Opioid Education, Post-operative Opioid Use